Our CSO David Dobnik discussed the available methods to assess vector genome integrity and the advantages dPCR-based solutions can bring.
David shared his perspective on multiplex assay design to accomplish this task and presented how our proprietary 𝗡𝗶𝗯𝗮𝗣𝗹𝗲𝘅® analytical platform can expedite and simplify this process.